Cancer studies often involve categorical data, such as patient demographics, genetic markers, and exposure to risk factors. The Chi Square Test helps researchers identify whether observed differences in cancer occurrences across different groups are due to chance or if there is a statistically significant association. This can inform preventive strategies and targeted therapies.
